| Product Code: ETC8258454 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mauritius Guanylate Cyclase-C Agonists Market Overview |
3.1 Mauritius Country Macro Economic Indicators |
3.2 Mauritius Guanylate Cyclase-C Agonists Market Revenues & Volume, 2021 & 2031F |
3.3 Mauritius Guanylate Cyclase-C Agonists Market - Industry Life Cycle |
3.4 Mauritius Guanylate Cyclase-C Agonists Market - Porter's Five Forces |
3.5 Mauritius Guanylate Cyclase-C Agonists Market Revenues & Volume Share, By Drug, 2021 & 2031F |
3.6 Mauritius Guanylate Cyclase-C Agonists Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Mauritius Guanylate Cyclase-C Agonists Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.8 Mauritius Guanylate Cyclase-C Agonists Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Mauritius Guanylate Cyclase-C Agonists Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Mauritius Guanylate Cyclase-C Agonists Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Mauritius Guanylate Cyclase-C Agonists Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gastrointestinal disorders in Mauritius |
4.2.2 Rising awareness about the benefits of guanylate cyclase-c agonists in treating such disorders |
4.2.3 Growing healthcare infrastructure and access to advanced medications in the region |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval and market entry |
4.3.2 High cost associated with guanylate cyclase-c agonists leading to limited affordability for some patients |
4.3.3 Competition from alternative treatment options for gastrointestinal disorders |
5 Mauritius Guanylate Cyclase-C Agonists Market Trends |
6 Mauritius Guanylate Cyclase-C Agonists Market, By Types |
6.1 Mauritius Guanylate Cyclase-C Agonists Market, By Drug |
6.1.1 Overview and Analysis |
6.1.2 Mauritius Guanylate Cyclase-C Agonists Market Revenues & Volume, By Drug, 2021- 2031F |
6.1.3 Mauritius Guanylate Cyclase-C Agonists Market Revenues & Volume, By Trulance, 2021- 2031F |
6.1.4 Mauritius Guanylate Cyclase-C Agonists Market Revenues & Volume, By Linzess, 2021- 2031F |
6.2 Mauritius Guanylate Cyclase-C Agonists Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Mauritius Guanylate Cyclase-C Agonists Market Revenues & Volume, By Irritable Bowel Syndrome, 2021- 2031F |
6.2.3 Mauritius Guanylate Cyclase-C Agonists Market Revenues & Volume, By Chronic Idiopathic Constipation, 2021- 2031F |
6.2.4 Mauritius Guanylate Cyclase-C Agonists Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Mauritius Guanylate Cyclase-C Agonists Market, By Dosage |
6.3.1 Overview and Analysis |
6.3.2 Mauritius Guanylate Cyclase-C Agonists Market Revenues & Volume, By Injection, 2021- 2031F |
6.3.3 Mauritius Guanylate Cyclase-C Agonists Market Revenues & Volume, By Tablet, 2021- 2031F |
6.3.4 Mauritius Guanylate Cyclase-C Agonists Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Mauritius Guanylate Cyclase-C Agonists Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Mauritius Guanylate Cyclase-C Agonists Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.4.3 Mauritius Guanylate Cyclase-C Agonists Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.4 Mauritius Guanylate Cyclase-C Agonists Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Mauritius Guanylate Cyclase-C Agonists Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Mauritius Guanylate Cyclase-C Agonists Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Mauritius Guanylate Cyclase-C Agonists Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Mauritius Guanylate Cyclase-C Agonists Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.5 Mauritius Guanylate Cyclase-C Agonists Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Mauritius Guanylate Cyclase-C Agonists Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Mauritius Guanylate Cyclase-C Agonists Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Mauritius Guanylate Cyclase-C Agonists Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Mauritius Guanylate Cyclase-C Agonists Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.5 Mauritius Guanylate Cyclase-C Agonists Market Revenues & Volume, By Others, 2021- 2031F |
7 Mauritius Guanylate Cyclase-C Agonists Market Import-Export Trade Statistics |
7.1 Mauritius Guanylate Cyclase-C Agonists Market Export to Major Countries |
7.2 Mauritius Guanylate Cyclase-C Agonists Market Imports from Major Countries |
8 Mauritius Guanylate Cyclase-C Agonists Market Key Performance Indicators |
8.1 Number of prescriptions for guanylate cyclase-c agonists in Mauritius |
8.2 Patient adherence rates to guanylate cyclase-c agonists treatment regimens |
8.3 Number of healthcare providers trained in prescribing and managing guanylate cyclase-c agonists |
8.4 Patient satisfaction scores related to the efficacy and tolerability of guanylate cyclase-c agonists |
9 Mauritius Guanylate Cyclase-C Agonists Market - Opportunity Assessment |
9.1 Mauritius Guanylate Cyclase-C Agonists Market Opportunity Assessment, By Drug, 2021 & 2031F |
9.2 Mauritius Guanylate Cyclase-C Agonists Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Mauritius Guanylate Cyclase-C Agonists Market Opportunity Assessment, By Dosage, 2021 & 2031F |
9.4 Mauritius Guanylate Cyclase-C Agonists Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Mauritius Guanylate Cyclase-C Agonists Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Mauritius Guanylate Cyclase-C Agonists Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Mauritius Guanylate Cyclase-C Agonists Market - Competitive Landscape |
10.1 Mauritius Guanylate Cyclase-C Agonists Market Revenue Share, By Companies, 2024 |
10.2 Mauritius Guanylate Cyclase-C Agonists Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here